Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2025-03-21 Proxy Solicitation & In…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2.2 Proxy General Meeting 24 April 2025 - FR - Final.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES" (Proxy for the General Shareholders' Meeting) and is dated for an assembly on April 24, 2025. It explicitly details the process for shareholders to appoint a proxy to vote on various resolutions, including the approval of annual accounts, remuneration reports, and board appointments. This document is a form used to solicit votes and appoint representatives for the Annual General Meeting (AGM). This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to request votes for meetings. While it relates to the AGM, the specific function is soliciting proxies, making PSI the most precise fit over AGM-R (which is usually the presentation materials).
2025-03-21 French
7.3. NL_ Remuneration Report 2024.pdf
Remuneration Information Classification · 98% confidence The document is titled "# 3.8 Remuneratieverslag" (Remuneration Report) and extensively discusses executive and director compensation, including fixed pay, annual bonuses (STI), long-term incentives (LTI), performance criteria for the CEO, and proposed changes to the remuneration policy for the upcoming year. This content directly aligns with the definition of a Remuneration Information report, which corresponds to the DEF 14A filing type in the US context, or a specific section within an Annual Report/Integrated Report focusing solely on compensation. Given the specific focus and the explicit mention of remuneration policy and results, the most appropriate classification is 'Remuneration Information' (DEF 14A). The document is comprehensive (209,100 chars) and appears to be the report itself, not just an announcement of its publication.
2025-03-21 Dutch
6.1. Statutory Account NBB_UCB SA_31.12.2024 _EN Final.pdf
Audit Report / Information Classification · 98% confidence The document explicitly states it contains "ANNUAL ACCOUNTS AND/OR OTHER DOCUMENTS TO BE FILED IN ACCORDANCE WITH THE BELGIAN COMPANIES AND ASSOCIATIONS CODE". It further confirms this by checking the box for "the ANNUAL ACCOUNTS in EUR approved by the general meeting" for the financial year ending 31/12/2024, and includes detailed Balance Sheet information. Although it is a filing related to annual accounts, the content provided is the actual financial statement/report structure, not just a brief announcement of publication. In the context of US SEC filings, this is analogous to a 10-K, but since the definitions provided include 'Annual Report (Code: 10-K)' and 'Audit Report / Information (Code: AR)', and this document is clearly the full set of annual accounts filed under Belgian law, 'AR' (Audit Report / Information) is the closest fit among the provided options for comprehensive annual statutory financial reporting, especially since '10-K' is typically reserved for US SEC filings, and this document contains the full accounts structure. Given the comprehensive nature and the explicit mention of 'ANNUAL ACCOUNTS', 'AR' is the most appropriate classification for a statutory annual financial report outside the US context, as it covers the results of the full financial year. FY 2024
2025-03-21 English
5.2. UCB_IAR_2024_FR.pdf
Annual Report Classification · 100% confidence The document is titled 'Rapport annuel intégré 2024' (2024 Integrated Annual Report) for UCB Biopharma. It contains a comprehensive overview of the company's performance, strategy, governance, sustainability declarations, and financial sections. It is clearly the full annual report document, not an announcement or a summary, as it includes detailed sections, a table of contents, and references to audited financial statements. FY 2024
2025-03-21 French
6.3. Statutory Accounts NBB_UCB SA_31.12.2024 _NL Final.pdf
Annual Report Classification · 100% confidence The document is a formal Belgian 'Jaarrekening' (Annual Accounts) for UCB SA, which includes balance sheets, lists of directors, and financial statements for the fiscal year 2024. This is a comprehensive statutory financial report required by law, fitting the definition of an Annual Report (10-K equivalent in this context). FY 2024
2025-03-21 Dutch
2.1 Proxy General Meeting 24 April 2025 - ENG - Final.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled "PROXY FOR THE GENERAL MEETING OF SHAREHOLDERS" and contains detailed instructions on how a shareholder can appoint a proxy holder to vote on their behalf at the meeting scheduled for April 24, 2025. It lists the agenda items, including approval of annual accounts, remuneration reports, and director appointments, which are typical items voted upon at an AGM. This document serves as the mechanism for shareholders to exercise their voting rights, making it a Proxy Solicitation/Information Statement related to the AGM. Since it is the proxy form itself, the most specific classification is Proxy Solicitation & Information Statement (PSI). While it relates to the AGM, PSI is more precise than AGM-R (which usually covers presentations/materials *at* the meeting).
2025-03-21 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.